MedTrace Logo

MiMBa Pregnancy Registry

NCT04825782 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 15000

Last updated 2021-04-01

No results posted yet for this study

Summary

The MiMBa (Malaria in Mothers and Babies) Pregnancy Registry aims to generate robust evidence on the safety of a range of antimalarials when used in pregnancy, particularly in the first trimester. This will be a multi-country observational study and will be deployed in several field sites in Africa.

Conditions

  • Malaria in Pregnancy
  • Pregnancy Related
  • Congenital Anomaly

Sponsors & Collaborators

  • Medicines for Malaria Venture

    collaborator OTHER

  • Worldwide Antimalarial Resistance Network

    collaborator NETWORK

  • Kenya Medical Research Institute

    collaborator OTHER

  • Liverpool School of Tropical Medicine

    lead OTHER

Principal Investigators

  • Feiko ter Kuile, MD, PhD · Liverpool School of Tropical Medicine

Eligibility

Min Age
15 Years
Max Age
49 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-02-22
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • Kenya

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04825782 on ClinicalTrials.gov